1. World Health Organization (WHO)– HIV/AIDS Fact Sheet, Updated November (2014). http://www.who.int/mediacentre/factsheets/fs360/en/
2. National AIDS Control Organisation (NACO), Ministry of health and Family Welfare (2014) Annual report. http://www.naco.gov.in/upload/2014%20mslns/NACO_English%202013-14.pdf
3. Sinha S, Ahmad H, Shekhar RC, Kumar N, Dar L, Samantaray JC, Sharma SK, Bhargava A, Pandey RM, Mitsuyasu RL, Fahey JL (2012) Prevalence of HIV drug resistance mutations in HIV type 1 isolates in antiretroviral therapy naïve population from northern India. AIDS Res Treat. doi: 10.1155/2012/905823
4. Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, d’Arminio Monforte A, Yust I, Bruun JN, Phillips AN, Lundgren JD (1998) Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 352:1725–1730. doi: 10.1016/S0140-6736(98)03201-2
5. Law MG, Li Y, McDonald AM, Cooper DA, Kaldor JM (2000) Estimating the population impact in Australia of improved antiretroviral treatment for HIV infection. AIDS 14:197–201